salmeterol xinafoate has been researched along with Tremor in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgartner, RA; Donohue, JF; Goodwin, E; Grogan, DR; Hanania, NA; Hanrahan, JP; Sciarappa, KA | 1 |
| Decramer, ML; Hanania, NA; Lötvall, JO; Yawn, BP | 1 |
| Grove, A; Lipworth, BJ | 1 |
| Calderaro, F; Califano, C; Cazzola, M; Di Pema, F; Donner, CF; Matera, MG; Vinciguerra, A | 1 |
| Cowan, JO; Flannery, EM; Hancox, RJ; Herbison, GP; McLachlan, CR; McRae, W; Taylor, DR | 1 |
| Dahl, R; Earnshaw, JS; Palmer, JB | 1 |
| Svedmyr, N; Ullman, A | 1 |
1 review(s) available for salmeterol xinafoate and Tremor
| Article | Year |
|---|---|
The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Blood Glucose; Cough; Ethanolamines; Formoterol Fumarate; Headache; Humans; Indans; Nasopharyngitis; Potassium; Pulmonary Disease, Chronic Obstructive; Quinolones; Respiratory Tract Infections; Salmeterol Xinafoate; Spasm; Tachycardia; Tremor | 2013 |
6 trial(s) available for salmeterol xinafoate and Tremor
| Article | Year |
|---|---|
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
Topics: Albuterol; Arrhythmias, Cardiac; Bronchitis; Bronchodilator Agents; Ethanolamines; Female; Forced Expiratory Volume; Formoterol Fumarate; Humans; Ipratropium; Male; Middle Aged; Myocardial Ischemia; Nebulizers and Vaporizers; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Salmeterol Xinafoate; Tremor | 2008 |
Evaluation of the beta 2 adrenoceptor agonist/antagonist activity of formoterol and salmeterol.
Topics: Adrenergic Agents; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Bronchodilator Agents; Cross-Over Studies; Ethanolamines; Exercise; Female; Formoterol Fumarate; Heart Rate; Humans; Male; Potassium; Propranolol; Salmeterol Xinafoate; Single-Blind Method; Tremor | 1996 |
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Forced Expiratory Flow Rates; Forced Expiratory Volume; Heart Rate; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Salmeterol Xinafoate; Terbutaline; Time Factors; Tremor | 1999 |
The influence of polymorphism at position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonist.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Amino Acid Sequence; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Drug Tolerance; Electrocardiography; Female; Forced Expiratory Volume; Heart Rate; Homozygote; Humans; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Receptors, Adrenergic, beta; Salmeterol Xinafoate; Tremor | 2000 |
Salmeterol: a four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Hemodynamics; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Tremor | 1991 |
Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Muscles; Peak Expiratory Flow Rate; Random Allocation; Salmeterol Xinafoate; Time Factors; Tremor | 1988 |